Scientific publications

PLOS One, 2025

A plasma-based protein signature association with all-cause mortality

Koziar N., Whetton A., Geifman N.

European Journal of Medical Research, 2025

Proteomics identifies complement protein signatures in patients with primary biliary cholangitis

Ma X., Dong H., Han J. et al.

npj Parkinson's Disease, 2025

The interplay between stress, inflammation and Parkinson’s disease: insights from the COVID-19 pandemic

van der Heide A., Kischkel B., Rovers C. et al.

British Journal of Pharmacology, 2025

UK Biobank: Transforming drug discovery and precision medicine

Bešević J., Said S., Nagy R. et al.

Experimental and Molecular Pathology, 2025

Persistent renin-angiotensin system and inflammatory dysregulation following COVID-19 impairs ischemic stroke recovery

Quek A., Teng O., Park J. et al.

Molecular Neurobiology, 2025

Mendelian Randomization Unlocks Stroke Therapeutics: Dioscin Inhibits CD27-Driven Neuroinflammation via Gut Microbiota Modulation

Tan H., Li S., Yan H. et al.

Neurocritical Care, 2025

Biomarker Differences in Aneurysmal Subarachnoid Hemorrhage: A Comparative Study of Patients with and Without Delayed CEREBRAL Ischemia

Santafé M., Quintana M., Sánchez A. et al.

Molecular Oncology, 2025

Next‐generation proteomics improves lung cancer risk prediction

Bhardwaj M., Frick C., Schöttker B. et al.

Metabolism, 2025

Air pollution exacerbates cardiovascular-kidney-metabolic syndrome and sarcopenia comorbidity via shared genetic-epigenetic mechanisms: A multi-omics and Mendelian Randomization study

Wei S., Shu Z., Li X. et al.

Frontiers in Medicine, 2025

Comprehensive proteome profiling of molecular endotypes in Japanese adults with moderate-to-severe atopic dermatitis

Serelli-Lee V., Ozeki A., Preuss C. et al.

Clinical Cancer Research, 2025

Phase II Trial of Cabozantinib in Combination with Nivolumab for Advanced Extrapancreatic Neuroendocrine Tumors

Perez K., Horick N., Baginksa J. et al.

Brain, Behavior, and Immunity, 2025

Searching for blood biomarkers and treatment targets in Women with fibromyalgia – Protein interaction patterns and anti-satellite glia cell IgG antibodies as promising candidates

Ekenstam K., Menezes J., Jakobsson J. et al.

Journal of Allergy and Clinical Immunology: Global, 2025

Inflammatory and fibrotic biomarkers in patients with atopic dermatitis treated with cendakimab

Li J., Gilvary C., Gao L. et al.

Nature Communications, 2025

An inherited mitochondrial DNA mutation remodels inflammatory cytokine responses in macrophages and in vivo in mice

Marques E., Burr S., Casey A. et al.

Cell Reports Medicine, 2025

Plasma proteomics identifies proteins and pathways associated with incident epilepsy

Zhang D., Wang Z., Zhang Y. et al.

Heart Rhythm, 2025

Cholesterol profiles and cholesterol-lowering medication in relation to the incidence of atrial fibrillation

Xu H., Li B., Zhang L. et al.

Journal of Pediatric Gastroenterology and Nutrition, 2025

A set of serum proteomic biomarkers differentiates celiac children from age and human leukocyte antigen‐matched healthy controls

Mandile R., di Tolla M., Carpinelli M. et al.

International Journal of Medical Sciences, 2025

Similarities and differences between Alzheimer's disease and schizophrenia: drug target Mendelian randomization and transcriptome analysis

Zhang Y., Shao J., Liang B. et al.

Medicine, 2025

Identification of circulating inflammatory proteins as potential drug targets for sepsis through Mendelian randomization and colocalization analyses

Wan F., Shen J., Tang J.

International Journal of Dermatology, 2025

Exonic Variation in HLA‐C , CFB , and TAP2 Associated With Increased Risk for Comorbid Crohn's Disease and Psoriasis

Shaw V., Byun J., Zhu C. et al.